$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Is daprodustat a treatment drug for renal anemia?
2026-02-01 22:25:32
Check Details
The efficacy of durvalumab/Infinifer combination chemotherapy in advanced pleural mesothelioma is uncertain
2026-02-01 22:25:32
Check Details
How to master the correct usage and dosage of zotuximab/veluoyin
2026-02-01 22:25:32
Check Details
Treprostinil dry powder inhaler (treprostinil)-Yutrepia dosage and usage
2026-02-01 22:25:32
Check Details
Does 0.01% Atropine Sulfate Eye Drops (EIKANCE) have the function of dilating mydriasis?
2026-02-01 22:25:32
Check Details
Is there macituximab/magenex oral medication?
2026-02-01 22:25:32
Check Details
Evaluation of the efficacy of somituximab (Mirvetuximab) in ovarian cancer
2026-02-01 22:25:32
Check Details
Explanation on whether talquetamab-tgvs is a targeted drug
2026-02-01 22:25:32
Check Details
How effective is dupilumab/dalbitux in treating eczema?
2026-02-01 22:25:32
Check Details
Single-dose normative study of febuxostat/pheblix
2026-02-01 22:25:32
Check Details
FDA approves treprostinil dry powder inhaler (Yutrepia) for the treatment of pulmonary arterial hypertension
2026-02-01 22:25:32
Check Details
Is Trelagliptin harmful to the body with long-term use?
2026-02-01 22:25:32
Check Details
1
2
...
2207
2208
2209
2210
2211
2212
2213
...
10213
10214
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Adagrasib Medication Management Guide for Special Populations
2
Olutasidenib (Rezlidhia): A Targeted Drug for IDH1-Mutated Relapsed/Refractory AML
3
Capmatinib Redefines Precision Therapy for MET-Mutated Lung Cancer
4
FDA Approves Dual Immunotherapy Combo: Tecvayli + Darzalex Faspro Transforms RRMM Treatment
5
Cabozantinib: Pivotal Advancements and Global Implications in Multi-Cancer Treatment with Multi-Kinase Inhibition
6
Pretomanid for Drug-Resistant TB: Risks and Management of 3-Year Treatment
7
SKYSCRAPER-02C Study: New Hope for Extensive-Stage Small Cell Lung Cancer Treatment
8
LPCAT3: The Key Player in MASH Progression to Hepatocellular Carcinoma
9
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer
10
Venetoclax Therapy Guidelines: Balancing Precision Targeting with Risk Management
11
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
12
A Comprehensive Guide to Benralizumab Adverse Reactions: Prevention and Management